Jan 17 (Reuters) -
The U.S. Justice Department on Friday accused pharmacy chain
operator Walgreens Boots Alliance ( WBA ) of contributing to the
U.S. opioid epidemic by filling millions of unlawful
prescriptions for addictive painkillers and other drugs.
The department
intervened
in a whistleblower lawsuit filed in federal court in
Chicago and accused Walgreens of ignoring "red flags" and
filling prescriptions for opioids and other controlled
substances that lacked a legitimate medical purpose.
"These practices allowed millions of opioid pills and
other controlled substances to flow illegally out of Walgreens
stores," Brian Boynton, the head of the Justice Department's
Civil Division, said in a statement.
The lawsuit alleged that by knowingly filling unlawful
prescriptions for controlled substances, Walgreens violated the
Controlled Substances Act. The government also alleged it
violated the False Claims Act when it then sought reimbursement
from federal health care programs, like Medicare, for the
prescriptions.
The lawsuit was announced after Walgreens filed its own
lawsuit on Thursday challenging what it said were new policies
the U.S. Drug Enforcement Administration had unlawfully adopted,
seeking to ensure pharmacies do not dispense controlled
substances for medically illegitimate purposes.
That lawsuit was filed in federal court in Tyler, Texas,
following what Walgreens had described as recently as last week
as active negotiations with the Justice Department for a
potential settlement to resolve claims it improperly dispensed
opioids.
The company's lawsuit targeted what Walgreens called new,
"arbitrary" rules the DEA imposed without going through the
required rulemaking process.
"We will not stand by and allow the government to put our
pharmacists in a no-win situation, trying to comply with 'rules'
that simply do not exist," Walgreens said in a statement.
Walgreens is among the drug manufacturers, distributors,
pharmacy operators and others who have collectively in recent
years agreed to pay about $50 billion to resolve lawsuits and
investigations by states and local governments accusing them of
helping fuel a deadly opioid addiction epidemic in the U.S.
The U.S. Centers for Disease Control and Prevention says
nearly 727,000 opioid overdose deaths occurred from 1999 to
2022.
The Justice Department last month announced a similar
lawsuit against Walgreens rival CVS that accused the
pharmacy chain of filling illegal opioid prescriptions and
contributing to a nationwide epidemic of opioid addiction.
Walgreens in 2022 agreed to pay up to $5.52 billion over 15
years to resolve thousands of lawsuits by state and local
governments accusing the company of fueling the U.S. opioid
epidemic.
Last month, Ohio's top court overturned a $650.9 million
judgment two local counties secured against Walgreens, CVS and
Walmart ( WMT ) in the first case to go to trial nationally over
allegations the pharmacies contributed to the epidemic.
(Reporting by Nate Raymond in Boston, Editing by Alexia
Garamfalvi)